Christopher Gibson, Director at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 60,000 shares at $4.25 ($170K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Seasonal sale ($170k) by Director — this insider has traded RXRX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 20,000 | $0 | 0.0% |
| 2 | $4.25 | 40,000 | $170K | 100.0% |
| Total | $2.83 avg | 60,000 | $170K | 100% |
| Filing → |
| RXRX | SELL | 2026-05-08 | $135K | — | Filing → |
| RXRX | SELL | 2026-04-24 | $144K | — | Filing → |
| RXRX | SELL | 2026-04-08 | $124K | — | Filing → |